[1]
N.-M. Cason, P. A. Babes, E. Béres, and K. Babes, “ASSESSMENT OF LONG TERM METABOLIC EFFECTS OF ATYPICAL ANTIPSYCHOTICS IN SCHIZOPHRENIA PATIENTS”, RJDNMD, vol. 26, no. 3, pp. 267-277, Oct. 2019.